Edgewise Therapeutics, Inc. EWTX EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s EPS (basic)?
- Edgewise Therapeutics, Inc. (EWTX) reported EPS (basic) of -$0.46 in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s EPS (basic) changed year-over-year?
- Edgewise Therapeutics, Inc.'s EPS (basic) decreased by 7.0% year-over-year, from -$0.43 to -$0.46.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s EPS (basic) has grown at a -24.6% compound annual growth rate (CAGR), from -$5.08 to -$1.64.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.